U S Physical Therapy Inc USPH
We take great care to ensure that the data presented and summarized in this overview for U S PHYSICAL THERAPY INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding USPH
View all-
Black Rock Inc. New York, NY2.29MShares$219 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.2MShares$115 Million0.01% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.12MShares$107 Million0.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.08MShares$103 Million0.0% of portfolio
-
Copeland Capital Management, LLC767KShares$73.3 Million1.16% of portfolio
-
State Street Corp Boston, MA668KShares$63.8 Million0.0% of portfolio
-
Eaton Vance Management Boston, MA567KShares$54.2 Million0.06% of portfolio
-
Southernsun Asset Management, LLC Memphis, TN547KShares$52.3 Million5.49% of portfolio
-
Boston Trust Walden Corp532KShares$50.8 Million0.32% of portfolio
-
Schroder Investment Management Group London, X0431KShares$41.2 Million0.04% of portfolio
Latest Institutional Activity in USPH
Top Purchases
Top Sells
About USPH
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
Insider Transactions at USPH
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2024
|
Carey P Hendrickson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
516
-2.46%
|
$49,536
$96.25 P/Share
|
|
Nov 25
2024
|
Richard Binstein EVP Gen'l Counsel & Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,128
-8.75%
|
$110,544
$98.52 P/Share
|
|
Nov 12
2024
|
Bernard A Harris Jr |
SELL
Open market or private sale
|
Direct |
2,000
-10.68%
|
$184,000
$92.95 P/Share
|
|
Nov 08
2024
|
Clayton Trier |
SELL
Open market or private sale
|
Direct |
2,000
-23.74%
|
$190,000
$95.78 P/Share
|
|
Nov 08
2024
|
Eric Joseph Williams Co-Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
2,000
-11.89%
|
$190,000
$95.84 P/Share
|
|
Nov 08
2024
|
Graham D. Reeve COO |
SELL
Open market or private sale
|
Indirect |
1,724
-19.52%
|
$165,504
$96.29 P/Share
|
|
Nov 08
2024
|
Nancy Ham |
SELL
Open market or private sale
|
Direct |
1,172
-51.31%
|
$112,512
$96.72 P/Share
|
|
Sep 03
2024
|
Kathleen A Gilmartin |
BUY
Open market or private purchase
|
Direct |
2,000
+9.57%
|
$172,000
$86.09 P/Share
|
|
Aug 21
2024
|
Graham D. Reeve COO |
SELL
Open market or private sale
|
Indirect |
1,724
-19.68%
|
$141,368
$82.5 P/Share
|
|
May 30
2024
|
Christopher J Reading Chairman of the Board and CEO |
SELL
Open market or private sale
|
Direct |
2,900
-2.94%
|
$290,000
$100.26 P/Share
|
|
May 29
2024
|
Christopher J Reading Chairman of the Board and CEO |
SELL
Open market or private sale
|
Direct |
1,000
-1.0%
|
$100,000
$100.13 P/Share
|
|
May 28
2024
|
Christopher J Reading Chairman of the Board and CEO |
SELL
Open market or private sale
|
Direct |
1,100
-1.09%
|
$112,200
$102.13 P/Share
|
|
May 20
2024
|
Regg E. Swanson |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+11.19%
|
-
|
|
May 20
2024
|
Anne Motsenbocker |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+20.2%
|
-
|
|
May 20
2024
|
Bernard A Harris Jr |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+7.07%
|
-
|
|
May 20
2024
|
Kathleen A Gilmartin |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+7.77%
|
-
|
|
May 20
2024
|
Clayton Trier |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+14.46%
|
-
|
|
May 20
2024
|
Carey P Hendrickson Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
201
-0.48%
|
-
|
|
May 20
2024
|
Nancy Ham |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+38.4%
|
-
|
|
May 16
2024
|
Richard Binstein EVP Gen'l Counsel & Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,111
-14.07%
|
$223,766
$106.34 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 57.1K shares |
|---|---|
| Open market or private purchase | 2K shares |
| Open market or private sale | 34.2K shares |
|---|---|
| Sale (or disposition) back to the issuer | 3.24K shares |
| Bona fide gift | 201 shares |